chapter six
medications . A standardized preparation of Pygeum africanum may be a useful treatment option , at least in the short term , for men with lower urinary symptoms consistent with benign prostatic hyperplasia .”
II . Ongoing Clinical Research
Different databases were used to identify the ongoing research studies related to benign prostatic hyperplasia ( BPH ). A total of 353 studies were found when the condition “ benign prostatic hyperplasia ” was searched and below is a summary of the findings :
1 . Research on Saw Palmetto Extract in Benign Prostatic Hyperplasia The study compared 160 mg twice a day of the herbal extract versus an identical placebo among men who had discontinued all other medications to treat BPH . The participants were seen in a clinic every 3 months for 1 year . The primary factor observed was a change in the American Urological Association Symptom Index score . The study results were reported in the New England Journal of Medicine in February 2006 . The authors concluded that in this study saw palmetto did not improve symptoms or objective measures of benign prostatic hyperplasia .
2 . Research Study on Serenoa repens on Inflammation Biomarkers in Urinary Symptoms Related to BPH ( Benign Prostatic Hyperplasia ) The study compared a lipidosterolic extract of Serenoa repens ( saw palmetto ) with a prescription medication for 90 days . The primary factors observed were changes from the baseline in urine and serum inflammation biomarkers . No study results were posted and no links to publications were provided .
3 . Research on the Efficacy of a Natural Extract Combined with Saw Palmetto in Benign Prostatic Hyperplasia Patients Compared to Saw Palmetto The study compared the oral administration of one capsule containing a combination of 250 mg of a natural extract and 160 mg of saw palmetto lipidic extract plus inactive fillers twice a day between meals to
38